Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Neupro (rotigotine) long-term extension in advanced Parkinson's Disease
NCT01631825Phase 3Completed
- Sponsor
- Otsuka Pharmaceutical Co., Ltd.
- Start
- Oct 2009
- Primary completion
- Jun 2012
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 3 trial of rotigotine in Parkinson's disease (PD), sponsored by Otsuka Pharmaceutical Co., Ltd.. Started Oct 2009; status: completed.
02
Drugs
rotigotine
03
Conditions
Parkinson's disease (PD)
Beyond the preview
Go deeper on NCT01631825.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT01631825.